Legal Representation
Attorney
Eric Kohli
USPTO Deadlines
Next Deadline
2186 days remaining
Section 8 Declaration Due (Principal Register)
Due Date
January 20, 2032
Grace Period Ends
July 20, 2032
Application History
16 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 20, 2026 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jan 20, 2026 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Dec 2, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 2, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 26, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 4, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 3, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 3, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 3, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 23, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 23, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 23, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 23, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 3, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jun 3, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 3, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Dietary and nutritional supplements; pharmaceutical preparations for medical treatment and disease prevention all for pain treatment, opioid and alcohol addiction treatment, low testosterone treatment, weight loss treatment, mold and Lyme disease treatment, and hormone treatment; compounded pharmaceutical preparations for medical use for pain treatment, opioid and alcohol addiction treatment, low testosterone treatment, weight loss treatment, mold and Lyme disease treatment, and hormone treatment; pharmaceutical tablets, capsules, and pills for medical use all for pain treatment, opioid and alcohol addiction treatment, low testosterone treatment, weight loss treatment, mold and Lyme disease treatment, and hormone treatment
First Use Anywhere:
May 31, 2023
First Use in Commerce:
Nov 30, 2024
Classification
International Classes
005